KUWAIT CITY, Nov 4: The Kuwaiti Ministry of Health announced the successful completion of two simultaneous robotic (remote) ...

Teleflex Inc (TFX) reports a robust 19.4% revenue increase, driven by strong performance in interventional and vascular segments, despite facing margin challenges and decreased cash flow.

Keenova Focused on Advancing Therapies to Address Unmet Patient Needs  Company Intends to Pursue Public Equity Listing in 2026  DUBLIN, Nov. 10, 2025 ...

As the European markets navigate a period of mixed performance, with the pan-European STOXX Europe 600 Index recently dipping after reaching new highs, investors are closely monitoring central bank ...

Teleflex Incorporated (NYSE: TFX) (the 'Company”) today announced financial results for the third quarter ended September 28, 2025.

BDX tops fourth-quarter fiscal 2025 earnings estimates and posts strong margin gains, with growth across all business ...

Mallinckrodt plc ("Mallinckrodt" or the "Company") today reported its financial results for the third quarter of 2025, which include combined business results following the completion of ...

Bactiguard Holding AB ( ($SE:BACTI.B) ) has shared an announcement. Bactiguard Holding AB has appointed its Nomination Committee for the upcoming ...

Q3 2025 Earnings Call November 6, 2025 8:00 AM ESTCompany ParticipantsLawrence Keusch - Vice President of Investor ...

With nearly 30,000 people on WA’s elective surgery waitlist, it is hoped the new two new medical facilities will help ease ...

SAUCON TWP., Pa. - Olympus will cut 2,000 positions from its global payroll. The medtech company, which is based in Tokyo, ...

Teleflex expects adjusted gross margin for 2025 to be approximately 59% and adjusted operating margin to be approximately 24.5%. Adjusted EPS guidance for 2025 is narrowed to $14 to $14.20, from ...